Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Amitriptyline Side Effects: Why Dose and Age Change the Whole Picture

Last updated November 5, 2026

Key Takeaways

  • Amitriptyline is a tricyclic antidepressant (TCA). Its well-known side effects, including drowsiness, dry mouth, constipation, and blurred vision, come from blocking receptors beyond the ones that help mood.
  • Dose changes the picture. Low doses of 10 to 30 mg, often used for pain or irritable bowel syndrome, were generally well tolerated in a large trial, while depression doses are usually 75 to 150 mg a day.
  • Heart effects matter. The FDA label warns about arrhythmias and conduction changes, especially at high doses, and amitriptyline isn't recommended in the recovery phase after a heart attack.
  • Older adults are more sensitive to its anticholinergic effects, including confusion, falls, and urinary retention, and the label advises starting low and monitoring closely.

Maybe your doctor prescribed a small dose of amitriptyline for nerve pain, migraines, or a sensitive gut, and now you’re groggy every morning. Or maybe you’re helping an older parent who started it and seems more confused or unsteady than before. Both experiences trace back to the same chemistry.

Amitriptyline blocks the reuptake of serotonin and norepinephrine, according to its DailyMed amitriptyline label. The trouble is that it also has strong anticholinergic effects on the systems that control saliva, bowel movement, and bladder emptying, and it’s sedating. The label describes it as an antidepressant with sedative effects and an atropine-like action. Using a drug this broad safely takes precision about dose and about who’s taking it.

Amitriptyline has a long and serious evidence base. In a Lancet network meta-analysis of 522 depression trials with 116,477 participants, every antidepressant beat placebo, and amitriptyline had the largest effect, with an odds ratio of 2.13. It’s also used off-label at lower doses for chronic pain and irritable bowel syndrome. The results are real, and the science is well established.

But a drug’s strength on average says little about how it will feel in your body, and at Siggy we don’t think older adults or people on low doses should get the same one-size explanation.

This guide breaks amitriptyline’s side effects down by mechanism, by dose, and by age, using the FDA label and recent trials. A licensed prescriber can then weigh those trade-offs against your health history, your other medications, and what you’re treating. That makes the choice specific to your body, rather than a generic warning list, and it rests on pharmacology.

What This Page Covers

Why Does Amitriptyline Cause So Many Side Effects?

Amitriptyline belongs to an older class called tricyclic antidepressants, or TCAs. Our guide to tricyclic antidepressants covers the whole class. What sets these drugs apart from newer antidepressants is how many receptor types they touch.

Blocking acetylcholine receptors causes anticholinergic effects such as dry mouth, constipation, urinary retention, and blurred vision. Sedation and low blood pressure on standing are also part of its profile. The label groups many of these under its anticholinergic and cardiovascular side effects, and warns about its atropine-like action in people with urinary retention or angle-closure glaucoma.

What Are the Most Common Amitriptyline Side Effects?

The label lists a wide range of effects. Here are the ones most worth knowing about, grouped by type.

  • Drowsiness and fatigue, one reason the label suggests bedtime dosing.
  • Dry mouth, constipation, and blurred vision.
  • Dizziness or lightheadedness when standing, from orthostatic hypotension.
  • Weight gain or loss.
  • Fast heartbeat or palpitations.

The sedation often shows up first. The label notes that a sedative effect may appear before the antidepressant effect, and a full antidepressant response may take as long as 30 days.

Less common but more serious effects include confusion, seizures, low sodium levels, and serotonin syndrome when combined with other serotonergic drugs. The label warns that hyponatremia, or low blood sodium, is more likely in older adults, people taking diuretics, and those who are dehydrated.

How Does Dose Change the Side Effects?

Dose is the biggest lever. For depression, the label’s usual outpatient starting dose is 75 mg a day in divided doses, which may be increased to 150 mg. Pain and gut conditions are often treated with much less. Those uses are off-label in the U.S., since the label’s only approved use is relief of depression symptoms.

The ATLANTIS randomized trial, the largest trial of a tricyclic in irritable bowel syndrome, randomized 463 people to amitriptyline starting at 10 mg and titrated up to 30 mg, or placebo. Amitriptyline improved symptoms, and 13% stopped it because of side effects, compared with 9% on placebo. The authors judged it safe and well tolerated at that dose.

Side effects still happen at low doses. In a Cochrane pain review of neuropathic pain trials, 55% of people taking amitriptyline had at least one side effect, compared with 36% on placebo, though serious side effects were rare.

Here’s how typical doses and tolerability compare across common uses, based on the label and the studies above.

Use Typical Dose Tolerability Evidence
Irritable bowel syndrome 10 to 30 mg 13% stopped vs 9% on placebo
Neuropathic pain Below antidepressant doses Side effects in 55% vs 36%
Depression, outpatient 75 to 150 mg Broad anticholinergic profile
Depression, older adults Lower doses, started slowly Higher sensitivity, fall risk

What Heart Cautions Come With Amitriptyline?

The heart warnings are the reason amitriptyline isn’t a casual choice. The label states that TCAs, particularly at high doses, have been reported to cause arrhythmias, sinus tachycardia, and prolonged conduction time, and that heart attack and stroke have been reported with drugs in this class. It isn’t recommended during the acute recovery phase after a heart attack, and people with cardiovascular disorders should be watched closely.

Real-world data support the dose link. In a BMJ QT study covering 38,397 adults with electrocardiograms, amitriptyline showed a dose-related increase in the QTc interval, a heart rhythm measure tied to arrhythmia risk.

Overdose is a separate and serious concern. The label warns that deaths may occur from overdose with this class, with cardiac rhythm problems, low blood pressure, and seizures among the critical signs. A UK antidepressant toxicity study describes older tricyclics as generally more toxic in overdose than SSRIs. The label advises prescribing the smallest quantity consistent with good care to reduce overdose risk.

Why Are Older Adults at Higher Risk?

Older adults face more of these side effects, and they tend to be more consequential. The label states that geriatric patients are particularly sensitive to amitriptyline’s anticholinergic effects, including fast heart rate, urinary retention, constipation, dry mouth, and blurred vision. It also lists central effects such as cognitive impairment, psychomotor slowing, confusion, sedation, and delirium.

Blood levels run higher with age, too. The label notes that slower gut transit and reduced liver metabolism mean older adults generally have higher plasma levels for a given dose, and it recommends starting low and observing closely.

Several lines of evidence explain why geriatric experts urge caution.

  • Falls: a medication falls meta-analysis found antidepressants were significantly associated with falls in older adults, and the amitriptyline label notes increased fall risk.
  • Cumulative burden: the AGS Beers Criteria flag drugs with strong anticholinergic properties as potentially inappropriate for adults 65 and older, and warn about combining several of them.
  • Dementia: an anticholinergic dementia study in JAMA Internal Medicine of 58,769 people with dementia and 225,574 controls found an association between anticholinergic antidepressants and dementia risk. It was observational, so it can’t prove cause.

If you’re caring for an older adult on amitriptyline, new confusion, unsteadiness, trouble urinating, or severe constipation are worth reporting promptly.

Which Drug Interactions Matter Most?

Amitriptyline is broken down partly by a liver enzyme called CYP2D6. The label notes that about 7% to 10% of Caucasians are poor metabolizers of this enzyme and can have much higher TCA levels at usual doses. Many SSRIs inhibit CYP2D6, so the label advises caution when combining a TCA with an SSRI or switching between them.

Other interactions on the label include MAO inhibitors, which are contraindicated, other anticholinergic drugs, and alcohol and sedatives, whose effects amitriptyline can intensify. Combining it with other serotonergic medications raises the risk of serotonin syndrome. Bring a full list of your medications and supplements to your prescriber.

When Should You Call Your Prescriber?

Call if side effects make it hard to function, if you notice confusion, trouble urinating, a racing or irregular heartbeat, fainting, or severe constipation. Don’t stop amitriptyline suddenly after long-term use. The label notes that abrupt stopping can cause nausea, headache, and malaise, and even gradual reduction can bring brief irritability, restlessness, and sleep changes.

If you have chest pain, a seizure, or signs of an overdose, call 911. If you’re having thoughts of harming yourself, call 911 or call or text 988.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions. If you’re taking amitriptyline and wondering whether the side effects are worth it, or whether a newer option might fit better, Siggy’s free, anonymous intake lets you describe your symptoms, health history, and current medications. The intake gathers structured information and doesn’t diagnose you on its own. A licensed prescriber reviews it before anything is prescribed.

Once you’re in care, you can check in with Siggy while your body adjusts and note side effects like grogginess or dizziness as they come up, and your clinician determines the timing of follow-up care. Siggy isn’t an emergency service. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Amitriptyline can work well, but its side effects depend on your dose, your age, your heart, and the other medications you take. Those details deserve a careful look, especially for older adults. Start your anonymous intake with Siggy to share your medication history without giving your name or email. It’s free, a licensed prescriber reviews your full picture before anything is prescribed, and you’ll get a downloadable summary you can bring to any clinician, including your primary care doctor. For a related medication, see our guide to nortriptyline side effects.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What are the most common side effects of amitriptyline?

Well-known side effects of amitriptyline include drowsiness, dry mouth, constipation, blurred vision, dizziness when standing, and weight change. Many of these come from its anticholinergic, or atropine-like, effects. In a large trial of the low doses used for irritable bowel syndrome, amitriptyline was generally well tolerated, while depression doses are several times higher.

Is amitriptyline safe for older adults?

Amitriptyline needs extra caution in older adults. Its FDA label says older patients are particularly sensitive to its anticholinergic effects, including confusion, sedation, delirium, urinary retention, and constipation, and may be at higher risk of falls. The label advises starting at low doses and monitoring closely, and the American Geriatrics Society Beers Criteria flag strongly anticholinergic drugs as potentially inappropriate for adults 65 and older.

Does amitriptyline affect the heart?

Yes, it can. The FDA label warns that tricyclic antidepressants, particularly at high doses, can cause arrhythmias, fast heart rate, and prolonged electrical conduction, and amitriptyline isn't recommended during the recovery phase after a heart attack. A large electronic health record study also found a dose-related increase in the QTc interval with amitriptyline. Tell your prescriber about any heart condition before starting.

Does low-dose amitriptyline still cause side effects?

It can, though low doses were generally well tolerated in a large trial. In the ATLANTIS trial of 10 to 30 mg a day for irritable bowel syndrome, 13% of people stopped amitriptyline because of side effects, compared with 9% on placebo, and the researchers judged it safe and well tolerated. Side effects such as drowsiness and dry mouth can still occur at low doses.

Does amitriptyline cause weight gain?

It can. The FDA label lists both weight gain and weight loss among amitriptyline's possible effects. If you notice your weight changing, bring it up with your prescriber, since dose adjustments or a different medication may help.

Can you stop amitriptyline suddenly?

You shouldn't stop amitriptyline suddenly after taking it for a long time. The FDA label notes that abrupt stopping can cause nausea, headache, and malaise, and even gradual reduction can bring brief irritability, restlessness, and sleep changes. Work with your prescriber on a tapering plan.

Sources

  1. U.S. National Library of Medicine, DailyMed. Amitriptyline hydrochloride tablets prescribing information. Claims verified against the Zydus Pharmaceuticals USA label (ANDA 210086), effective March 25, 2025.
  2. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366.
  3. Ford AC, Wright-Hughes A, Alderson SL, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402(10414):1773-1785.
  4. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2015;(7):CD008242.
  5. Castro VM, Clements CC, Murphy SN, et al. QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ. 2013;346:f288.
  6. Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry. 2010;196(5):354-358.
  7. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Archives of Internal Medicine. 2009;169(21):1952-1960.
  8. 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):2052-2081.
  9. Coupland CAC, Hill T, Dening T, et al. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Internal Medicine. 2019;179(8):1084-1093.